GFOR

Graf Acquisition Corp. IV

A special purpose acquisition company (SPAC), a type of "blank-check" firm that raises money in order to take a private business public. Founded in 2021 by serial SPAC founder James Graf and based in The Woodlands, Texas, it went public that year and merged with NKGen Biotech, a clinical-stage biotech developing natural killer cell therapies. When the deal closed in October 2023, the company took the name NKGen Biotech and began trading on the Nasdaq.

Common stock of Graf Acquisition Corp. IV, a SPAC that completed business combination with NKGen Biotech — Merged with NKGen Biotech in September 2023

No Schedule 13D or 13G filings recorded.